Summit Therapeutics total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.503B, a 130.16% increase year-over-year.
Summit Therapeutics total liabilities and share holders equity for 2023 was $0.203B, a 69.44% decline from 2022.
Summit Therapeutics total liabilities and share holders equity for 2022 was $0.664B, a 485.82% increase from 2021.
Summit Therapeutics total liabilities and share holders equity for 2021 was $0.113B, a 10.61% increase from 2020.
Summit Therapeutics Total Liabilities and Share Holders Equity 2015-2024 | SMMT